Klinikum Südstadt Rostock
Rostock, Germany
General hospital in Rostock, Mecklenburg-Vorpommern
Südring 81, 18059 Rostock
About Klinikum Südstadt Rostock
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
German Breast Group
3
AGO Study Group
2
German High-Grade Non-Hodgkin's Lymphoma Study Group
2
Hoffmann-La Roche
2
AGO Research GmbH
1
AIO-Studien-gGmbH
1
Arcagy Research
1
Charite University, Berlin, Germany
1
Dr. med. Lars-Olof Muegge
1
Gilead Sciences
1
Heinrich-Heine University, Duesseldorf
1
Clinical Trials at Klinikum Südstadt Rostock
During the past decade, Klinikum Südstadt Rostock conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 4 clinical trials were completed, i.e. on
average, 26.7% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 4 clinical trials were completed. i.e. 80%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Rituximab and Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With B-Cell Non-Hodgkin's Lymphoma
2005-11-01
2018-02-01
Completed
700
Comparison of Paclitaxel/Carboplatin and Lonafarnib to Paclitaxel/Carboplatin for First-line Treatment of Ovarian Cancer
2006-01-01
2011-12-01
Completed
105
Rituximab and Combination Chemotherapy in Treating Older Patients With Previously Untreated B-Cell Lymphoma
2004-02-01
2015-11-01
Completed
586
Combination Chemotherapy With or Without Darbepoetin Alfa in Treating Women With Stage III Breast Cancer
2004-01-01
Unknown status
1,234
Neoadjuvant Chemotherapy Including Sorafenib in Women With Previously Untreated Primary Breast Cancer
2007-11-01
2011-12-01
Completed
36
Efficacy and Safety of Farletuzumab (MORAb-003) in Combination With Carboplatin and Taxane in Participants With Platinum-sensitive Ovarian Cancer in First Relapse
2009-04-16
2013-04-12
Terminated
1,100
Treatment Optimization in Patients With Untreated Multiple Myeloma
2013-08-01
2018-12-31
Terminated
85
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Klinikum Südstadt Rostock" #1 sponsor was "German Breast Group" with 3 trials, followed by "AGO Study Group" with 2 trials
sponsored, "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "AGO Research GmbH"
with 2 trials sponsored. Other sponsors include 8 different institutions and
companies that sponsored additional 18 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Südstadt Rostock"
#1 collaborator was "Bayer" with 2 trials as a collaborator, "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 2 trials as a collaborator, "Analyze & Realize" with 1 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 1 trials as a collaborator and "Arbeitsgemeinschaft Gynaekologishe Onkologie Germany" with 1 trials as a collaborator. Other collaborators include 21 different institutions and companies that were
collaborators in the rest 31 trials.
Clinical Trials Conditions at Klinikum Südstadt Rostock
According to Clinical.Site data, the most researched conditions in "Klinikum Südstadt Rostock" are
"Ovarian Cancer" (5 trials), "Breast Cancer" (3 trials), "Fallopian Tube Cancer" (2 trials), "Lymphoma" (2 trials) and "Adult-Onset Still´s Disease" (1 trials). Many other conditions were trialed in "Klinikum Südstadt Rostock" in a lesser frequency.
Clinical Trials Intervention Types at Klinikum Südstadt Rostock
Most popular intervention types in "Klinikum Südstadt Rostock" are "Drug" (20 trials), "Biological" (3 trials), "Procedure" (3 trials), "Other" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.
The name of intervention was led by "Carboplatin" (5 trials), "Paclitaxel" (3 trials), "Placebo" (3 trials), "cyclophosphamide" (3 trials) and "doxorubicin hydrochloride" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Klinikum Südstadt Rostock
The vast majority of trials in "Klinikum Südstadt Rostock" are
13 trials for "All" genders and 10 trials for "Female" genders.
Clinical Trials Status at Klinikum Südstadt Rostock
Currently, there are NaN active trials in "Klinikum Südstadt Rostock".
undefined are not yet recruiting,
6 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 9 completed trials in Klinikum Südstadt Rostock,
undefined suspended trials,
and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Klinikum Südstadt Rostock, 0 "Phase 1"
clinical trials were conducted, 9 "Phase 2" clinical
trials and 9 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 4 trials that are defined as “Not Applicable".
Departments of Klinikum Südstadt Rostock
Klinikum Südstadt Rostock has several departments that took part in Clinical trials: "Klinikum Südstadt Rostock, Innere Medizin III" - 2 trials
Departments List
Name
City
Trials